Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0E7RQ
|
|||
| Former ID |
DIB007481
|
|||
| Drug Name |
SNN-0029
|
|||
| Synonyms |
VEGF (intracerebroventricular, amyotrophic lateral sclerosis), NeuroNova/VIB/Genentech
Click to Show/Hide
|
|||
| Indication | Lateral sclerosis [ICD-11: 8B61] | Phase 1/2 | [1] | |
| Company |
Flanders Interuniversity Institute for Biotechnology (VIB)
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01384162) An Open Label, Safety and Tolerability Continuation Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Neuronova. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.